Dr Reddys Laboratories (RDY) Other Non-Current Assets (2012 - 2026)
Dr Reddys Laboratories (RDY) recorded quarterly Other Non-Current Assets of $13.4 million in Q1 2026, up 9.12% quarter-over-quarter from $12.3 million in Q3 2025, and up 19.48% on a YoY basis from $11.2 million in Q1 2025.
Dr Reddys Laboratories (RDY) Other Non-Current Assets (2012 - 2026) Analysis & Trends
Dr Reddys Laboratories' Other Non-Current Assets history runs 14 years deep, the most recent figure standing at $13.4 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 19.48% year-over-year to $13.4 million; the TTM figure through Mar 2026 stood at $13.4 million (up 19.48% YoY), while the FY2026 annual figure was $13.0 million, up 8.33% from the prior year.
- Other Non-Current Assets was $13.4 million for Q1 2026 at Dr Reddys Laboratories, up from $12.3 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $64.4 million in Q3 2023 to a low of $9.7 million in Q1 2023.
- Historically, Other Non-Current Assets has averaged $23.8 million across 5 years, with a median of $15.7 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets jumped 185.0% in 2023, then slumped 72.0% in 2024.
- A 5-year view of Other Non-Current Assets shows it stood at $22.6 million in 2022, then surged by 185.0% to $64.4 million in 2023, then tumbled by 72.0% to $18.0 million in 2024, then slumped by 31.83% to $12.3 million in 2025, then rose by 9.12% to $13.4 million in 2026.
- The last three Other Non-Current Assets figures came in at $13.4 million (Q1 2026), $12.3 million (Q3 2025), and $11.2 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Dr Reddys Laboratories | 122.03 Mn | -51.98 Mn | 368.55 Mn | 13.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.41 Mn |
| Sep 30, 2025 | 12.29 Mn |
| Mar 31, 2025 | 11.22 Mn |
| Sep 30, 2024 | 18.03 Mn |
| Mar 31, 2024 | 19.65 Mn |
| Sep 30, 2023 | 64.38 Mn |
| Jun 30, 2023 | 54.92 Mn |
| Mar 31, 2023 | 9.73 Mn |
| Sep 30, 2022 | 22.59 Mn |
| Mar 31, 2022 | 11.89 Mn |
| Dec 31, 2021 | 31.00 Mn |
| Sep 30, 2021 | 38.95 Mn |
| Jun 30, 2021 | 35.14 Mn |
| Mar 31, 2021 | 11.44 Mn |
| Dec 31, 2020 | 51.87 Mn |
| Sep 30, 2020 | 48.11 Mn |
| Jun 30, 2020 | 47.86 Mn |
| Mar 31, 2020 | 11.65 Mn |
| Dec 31, 2019 | 43.04 Mn |
| Sep 30, 2019 | 12.73 Mn |